6 Results.
Showing 1 to 6
|
Summary:
Open House Biologics Discount Contracts 2022-21 - Clostridium Botulinum Toxin Type A (product Name: Dysline(r))
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
30 Apr 2024
|
|
Summary:
Open House Drug Discount Agreements Botulinum Toxin Type A, Finished Drug Name: Dysport, Atc M03ax21
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
05 May 2024
|
|
Summary:
Open House Biologics Discount Contracts 2022-05 Clostridium Botulinum Toxin Type A (product Name: Xeomin(r))
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
30 Apr 2024
|
|
Summary:
Open House Biologics Discount Contracts 2022-04 Clostridium Botulinum Toxin Type A (product Name: Dysport(r))
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
30 Apr 2024
|
|
Summary:
Open House Biologics Discount Contracts 2022-02 Clostridium Botulinum Toxin Type A (product Name: Botox(r))
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
30 Apr 2024
|
|
Summary:
Dynamic System For The Procurement Of The Public Administration For The Supply Of Goods And Services For Healthcare - Id 2322
Sector:
Pharmaceuticals
Country:
Italy Estimated Cost:
EUR 3500000000 Notice Type:
Tender Notice
Deadline:
24 Jan 2026
|
|
|
Healthcare and Medicine